How should a child with low mean platelet volume, thrombocytosis, lymphocytosis, and eosinophilia be evaluated and managed?

Evaluation and Management of Pediatric Patient with Low MPV, High Platelet Count, Lymphocytosis, and Eosinophilia

This constellation of findings—thrombocytosis with low mean platelet volume, lymphocytosis, and eosinophilia—strongly suggests secondary (reactive) thrombocytosis rather than primary thrombocytosis, and requires systematic evaluation to identify the underlying cause, most commonly infection with anemia, iron deficiency, or inflammatory conditions.

Initial Diagnostic Approach

Confirm True Thrombocytosis

• Exclude pseudothrombocytosis by reviewing the peripheral blood smear to rule out red blood cell fragments or other artifacts that may falsely elevate automated platelet counts 1
• Verify platelet count is ≥450 × 10⁹/L, which defines thrombocytosis in children 2, 3

Key Laboratory Evaluation

The following tests should be obtained to identify the underlying cause:

• Complete blood count with differential to assess for anemia and quantify lymphocytosis and eosinophilia 4
• Peripheral blood smear review to assess platelet morphology, confirm cell counts, and evaluate for atypical features 4
• Iron studies (serum ferritin, iron, total iron-binding capacity) to exclude iron deficiency, which is the second most common cause of reactive thrombocytosis in children 4, 2
• Inflammatory markers including C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) to identify underlying inflammatory or infectious processes 4
• Stool examination for ova and parasites given the eosinophilia, which may indicate parasitic infection 1

Distinguish Primary from Secondary Thrombocytosis

Low MPV strongly favors reactive (secondary) thrombocytosis over primary thrombocytosis. 2, 5, 6

• In reactive thrombocytosis, MPV is typically decreased and inversely related to platelet count 2, 5, 6
• In primary thrombocytosis (essential thrombocythemia, chronic myeloid leukemia), platelet large cell ratio (P-LCR) is typically elevated (>26.10% for CML, >23.05% for chronic myeloproliferative disorders) 5, 6
• Primary thrombocytosis is extremely rare in children, occurring in only 1 per million children—60 times less common than in adults 3

Common Etiologies in This Clinical Context

Most Likely Causes (in order of frequency):

1. Infection with concurrent anemia (48.3% of cases)—the most common cause of secondary thrombocytosis in children 2

   • Respiratory infections account for 28.3% of infectious causes 2
   • The combination of lymphocytosis and eosinophilia may indicate viral infection or parasitic disease 7, 1

2. Iron deficiency anemia alone (17.2% of cases) 2

   • Severity of thrombocytosis increases with severity of anemia (p=0.021) 2
   • Thrombocytosis is most commonly associated with iron deficiency among all causes of anemia 2

3. Infection alone (16.2% of cases) 2

4. Pleural infection/empyema should be considered given the specific association with thrombocytosis 8

   • Secondary thrombocytosis (platelet count >500 × 10⁹/L) occurs in 79-93% of children with empyema 8
   • Counts typically peak at 2 weeks and normalize by 3 weeks of illness 8

Important Atypical Features to Evaluate

Bone marrow examination is NOT routinely necessary if the clinical presentation is typical for reactive thrombocytosis 7, 9, 4. However, consider bone marrow aspiration if any of the following atypical features are present:

• Fever, bone or joint pain 9
• Family history of thrombocytosis or easy bruising 9
• Skeletal or soft-tissue morphologic abnormalities 9
• Non-petechial rash or lymphadenopathy 9
• Abnormal hemoglobin, white blood cell count, or white cell morphology beyond simple lymphocytosis/eosinophilia 9
• Platelet count persistently >1,000 × 10⁹/L (extreme thrombocytosis), which occurs in only 0.5-3% of children and may warrant hematology consultation 1, 3

Management Principles

No Antiplatelet Therapy Required

Secondary thrombocytosis in children is benign and does not require antiplatelet therapy, even with extreme thrombocytosis. 8

• No thromboembolic complications were reported in six studies totaling 1,007 children with secondary thrombocytosis 8
• Platelet function remains normal even with counts >500 × 10⁹/L 8
• Low-dose aspirin cannot be recommended in children due to risk of Reye syndrome and platelet dysfunction 10

Treatment of Underlying Cause

• Address the identified underlying condition (infection, iron deficiency, inflammation) 2, 3
• Monitor platelet counts during treatment; thrombocytosis typically resolves as the underlying condition improves 8, 2

Follow-Up Strategy

• Repeat complete blood count in 2-4 weeks after initiating treatment for the underlying cause 3
• If thrombocytosis persists, is unexplained, or is symptomatic, consultation with pediatric hematology is required 3
• In the majority of cases, no specific treatment for thrombocytosis itself is necessary; close monitoring is sufficient 3

Critical Pitfalls to Avoid

• Do not assume primary thrombocytosis without thorough evaluation for secondary causes, as primary disease is exceedingly rare in children (1 in 1,000) 3
• Do not initiate antiplatelet therapy for reactive thrombocytosis, as it provides no benefit and carries risk 8, 10
• Do not perform routine bone marrow examination in children with typical features of reactive thrombocytosis, as it is unnecessary and invasive 7, 9, 4
• Do not overlook iron deficiency, which is frequently missed but is a leading cause of thrombocytosis in children 4, 2
• Recognize that eosinophilia and atypical lymphocytes may occur in children with immune thrombocytopenia and do not automatically indicate alternative diagnoses 7